AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2016
May 24, 2016
32870_dirs_2016-05-23_585fcc26-42a9-4dca-bbbc-1a5b08ad3171.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-05-19
Reporting Person: Richard Ronald (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-19 | Common Stock | A | 5985 | $0.00 | Acquired | 19718 | Direct |
Footnotes
F1: Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
F2: The restricted stock units vest in three equal annual tranches beginning in May 2017.
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3